|
||
|
||
| [Home Page] [Previous Menu] [Search] |
B-GT/25: Regulatory and clinical data
(Authors: M. Sneyers and M. Goossens - Last revised:
October 1, 2010
)
Title |
An open-label, phase I, dose-escalation and safety study of two intramuscular injections at dose of 2.9 log or 4 log CCID50 of the recombinant HIV I clade B measles vaccine vector in healthy adults. |
Company or sponsor |
Institut Pasteur - Paris |
Pharmaceutical study code |
|
| EudraCT number | |
Phase |
phase I |
Unicenter/multicenter study |
unicenter |
| Clinical data | see table 2 |
Installations |
UZ Gent |
Authorisation procedure 1 |
contained use, subsequent use (see relevant regulation) |
Application numbers |
SBB/219/2010/0609 |
User(s) |
Dr. Geert Leroux-Roels |
Receipt date |
08/07/2010 |
Status |
trial running |
|